Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Saima Chohan"'
Autor:
Stephen J. Rozzo, Alan M. Mendelsohn, Alice B. Gottlieb, Siba P. Raychaudhuri, Proton Rahman, Saima Chohan, Philip J. Mease, Richard C Chou, Michael E. Luggen, Ferran J Garcia Fructuoso
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo evaluate efficacy and safety of the anti-interleukin-23p19 monoclonal antibody tildrakizumab in patients with psoriatic arthritis (PsA).MethodsIn this randomised, double-blind, placebo-controlled, phase IIb study, patients with active Ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45699aa413018d161e9029b076da7135
https://doi.org/10.1136/annrheumdis-2020-219014
https://doi.org/10.1136/annrheumdis-2020-219014
Autor:
Elena Korneva, Sergey Grishin, Eugen Feist, Evgeniy L Nasonov, Saeed Fatenejad, Mikhail Samsonov, Anna Rowińska-Osuch, Saima Chohan
Publikováno v:
Rheumatology. 60
Background/Aims Olokizumab (OKZ) is a new humanised monoclonal antibody targeting IL-6 directly. Here we present the results of a global randomised clinical trial (RCT) in patients (pts) with RA. Methods This double-blind, placebo (PBO) and active co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d5904116098f157c3e26041bb26359a
https://doi.org/10.1093/rheumatology/keab247.126
https://doi.org/10.1093/rheumatology/keab247.126
Autor:
Alan M. Mendelsohn, Richard C Chou, Michael E. Luggen, Alice B. Gottlieb, P. J. Mease, Saima Chohan, Ana Maria Orbai, Proton Rahman, Siba P. Raychaudhuri, F. J. García Fructuoso, Stephen J. Rozzo
Publikováno v:
Annals of the Rheumatic Diseases. 79:145-146
Background:Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved to treat moderate to severe plaque psoriasis and is under investigation for treatment of psoriatic arthritis (PsA).1Objectives:To evaluate effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2906765078cb825a40410abfdfa2e55
https://doi.org/10.1136/annrheumdis-2020-eular.3908
https://doi.org/10.1136/annrheumdis-2020-eular.3908
Autor:
Saima Chohan, Vibeke Strand, Stephen J. Rozzo, Alan M. Mendelsohn, A. Kavanaugh, P. J. Mease, Richard C Chou
Publikováno v:
Annals of the Rheumatic Diseases. 79:1702-1703
Background:Tildrakizumab (TIL), an anti–interleukin (IL)-23p19 monoclonal antibody, is approved in the US, EU, and Australia for treatment of moderate-to-severe plaque psoriasis.1A randomised, double-blind, placebo-controlled, multiple-dose, phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d3d47c1be636e503cc4b3af56b1524a
https://doi.org/10.1136/annrheumdis-2020-eular.3907
https://doi.org/10.1136/annrheumdis-2020-eular.3907
Autor:
Ferran J Garcia Fructuoso, Kristine E Nograles, Philip J. Mease, Saima Chohan, Richard C Chou, Michael E. Luggen, Alan M. Mendelsohn
Publikováno v:
Oral Presentations.
Background Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved for moderate-to-severe plaque psoriasis treatment and is under investigation for psoriatic arthritis (PsA). Objectives To evaluate the 24-week e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::737e7ee25e5e432baf497dc8bb5b5ead
https://doi.org/10.1136/annrheumdis-2019-eular.8669
https://doi.org/10.1136/annrheumdis-2019-eular.8669
Autor:
Richard C Chou, Michael E. Luggen, Ferran J Garcia Fructuoso, Philip J. Mease, Rocco Ballerini, Alice B. Gottlieb, Saima Chohan, Alan M. Mendelsohn
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::558d5728a4a2c3dcece2a86bc19cd5c8
https://doi.org/10.1016/j.jaad.2020.06.749
https://doi.org/10.1016/j.jaad.2020.06.749
Autor:
Alice B Gottlieb, Ferran J Garcia Fructuoso, Philip J. Mease, Alan M. Mendelsohn, Saima Chohan, Richard C Chou, Michael E. Luggen
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 4:s43
not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0047d51ad3d2b235bb3cfc286d0ce3e3
https://doi.org/10.25251/skin.4.supp.43
https://doi.org/10.25251/skin.4.supp.43
Publikováno v:
Rheumatic Disease Clinics of North America. 40:357-374
Gout is a common disorder with clinical signs and symptoms resulting from inflammatory responses to monosodium urate crystals deposited in tissues from extracellular fluids saturated for urate. Long-term management of gout focuses on nonpharmacologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add344b96f12e0359aafbefda2855137
https://doi.org/10.1016/j.rdc.2014.01.012
https://doi.org/10.1016/j.rdc.2014.01.012
Publikováno v:
Arthritis Care & Research. 64:256-261
Objective To compare the characteristics of female versus male gout patients and assess urate-lowering efficacy and safety of febuxostat or allopurinol treatment in women with gout. Methods This was a retrospective analysis of 4,101 hyperuricemic (se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f5d526a36c93f72c1e075761a279f9
https://doi.org/10.1002/acr.20680
https://doi.org/10.1002/acr.20680
Autor:
Michael A Becker, Saima Chohan
Publikováno v:
Current Opinion in Internal Medicine. 7:308-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28f773c639fec7080203b2db350caa13
https://doi.org/10.1097/mci.0b013e328303e7cf
https://doi.org/10.1097/mci.0b013e328303e7cf